Häuser Winfried, Petzke Frank, Radbruch Lukas, Tölle Thomas R
Internal Medicine 1, Klinikum Saarbrücken, Winterberg 1, D-66119 Saarbrücken, Germany.
Department of Psychosomatic Medicine & Psychotherapy, Technische Universität München, Ismaningerstraβe 22, D-81675 München, Germany.
Pain Manag. 2016;6(3):249-63. doi: 10.2217/pmt.16.5. Epub 2016 Mar 18.
The rise of opioid prescriptions and associated deaths ('opioid epidemic') in North America has evoked worldwide discussions on the long-term efficacy and safety of long-term opioid therapy (LtOT) for chronic noncancer pain (CNCP). We discuss if the opioid epidemic is a real worldwide or a more North American phenomenon. We consider reasons of the opioid epidemic. We highlight differences in the appraisal of the evidence of recent systematic reviews on LtOT for CNCP of US and European authors. We discuss similarities and differences of recent North American and European guidelines on LtOT for chronic CNCP. We point out potential indications and contraindications of LtOT in CNCP syndromes.
北美阿片类药物处方量的增加及其相关死亡事件(“阿片类药物流行”)引发了全球范围内关于长期阿片类药物治疗(LtOT)用于慢性非癌性疼痛(CNCP)的长期疗效和安全性的讨论。我们探讨阿片类药物流行是全球普遍存在的现象还是更局限于北美的现象。我们分析阿片类药物流行的原因。我们强调美国和欧洲作者对近期关于CNCP的LtOT系统评价证据评估的差异。我们讨论近期北美和欧洲关于慢性CNCP的LtOT指南的异同。我们指出CNCP综合征中LtOT的潜在适应证和禁忌证。